Login / Signup

Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma.

Sridurga MithraprabhuJohn ReynoldsRose TurnerHang QuachNoemi HorvathIan KerridgeAnna KalffKrystal BerginJay HockingFlora YuenTiffany KhongBrian M DurieAndrew Spencer
Published in: Blood cancer journal (2023)
Keyphrases
  • multiple myeloma
  • circulating tumor
  • cell free
  • single molecule
  • free survival